GH Research Plc (GHRS)
27.36
+0.38
(+1.41%)
USD |
NASDAQ |
Sep 01, 16:00
27.36
0.00 (0.00%)
After-Hours: 20:00
GH Research Cash from Operations (Annual) : -43.55M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -43.55M |
| December 31, 2024 | -42.28M |
| December 31, 2023 | -33.34M |
| December 31, 2022 | -26.20M |
| Date | Value |
|---|---|
| December 31, 2021 | -15.28M |
| December 31, 2020 | -0.33M |
| December 31, 2019 | -0.289M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Atai Beckley, Inc. | -102.68M |
| Avadel Pharmaceuticals Plc | -- |
| Jazz Pharmaceuticals Plc | 1.356B |
| Eli Lilly & Co. | 16.81B |
| Perrigo Co. Plc | 238.50M |